(Q43202335)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682660%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

A unified definition of clinical anthracycline resistance breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682660%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Asmar L

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682660%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Valero V

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682660%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Hortobagyi G

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682660%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682660%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682660%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682660%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682660%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

529-534

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682660%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1054/bjoc.1999.0958

4 November 2019

exact match

0 references

cites work

The efficacy of chemotherapy with docetaxel and paclitaxel in anthracycline-resistant breast cancer (Review).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363337

Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363337

Vinorelbine (navelbine) as a salvage treatment for advanced breast cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363337

The M. D. Anderson Cancer Center experience with Taxol in metastatic breast cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363337

Present status of anthracyclines in the adjuvant treatment of breast cancer.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363337

Current status of adjuvant systemic therapy for primary breast cancer: progress and controversy

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363337

Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363337

High-dose paclitaxel with granulocyte colony-stimulating factor in patients with advanced breast cancer refractory to anthracycline therapy: a European Cancer Center trial.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363337

Management of breast cancer: status and future trends.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363337

An effective low-dose mitomycin regimen for hormonal- and chemotherapy-refractory patients with metastatic breast cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363337

Evaluation of survival data and two new rank order statistics arising in its consideration

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363337

Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363337

Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363337

Multivariate analysis of prognostic factors in metastatic breast cancer.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363337

A comparative randomized trial of vinca alkaloids in patients with metastatic breast carcinoma

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10682660

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A randomized trial of two dosage schedules of mitomycin C in advanced breast carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10682660

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10682660

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1054/BJOC.1999.0958

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682660%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 November 2019

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10682660%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

PubMed publication ID

10682660

1 reference